跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,707 条关于
“Lynch Regenerative Medicine”
全部
17,707
临床试验
5,957
药物
509
机构
614
资讯
10,627
上个月
Lynch Regenerative Medicine Completes Enrollment in Phase II Trial of rhPDGF-BB for Full-Thickness Head and Neck Wound Healing
去年
MeiraGTx's AAV2-hAQP1 Receives FDA RMAT Designation for Radiation-Induced Xerostomia
2年前
BridgeBio's BBP-812 Receives FDA RMAT Designation for Canavan Disease Gene Therapy
去年
Allogene's ALLO-316 Receives FDA RMAT Designation for Advanced Renal Cell Carcinoma
2年前
Poseida Therapeutics' P-BCMA-ALLO1 Receives FDA RMAT Designation for Relapsed/Refractory Multiple Myeloma
去年
€13.6M EU-Funded PREDI-LYNCH Project Aims to Transform Cancer Screening for Lynch Syndrome Patients
去年
AI Revolutionizes Regenerative Medicine Drug Development, Accelerating Parkinson's Treatment Research
11个月前
FDA Issues New RMAT Guidance to Accelerate Regenerative Medicine Development
2年前
Poseida Therapeutics' P-BCMA-ALLO1 Receives FDA RMAT Designation for Relapsed/Refractory Multiple Myeloma
去年
Breakthrough Innovations in Regenerative Medicine Target Parkinson's, Heart Disease, and AMD
第 1 页，共 1063 页
上一页
下一页
